Literature DB >> 8906082

Frequency of phenotype-genotype discrepancies at the apolipoprotein E locus in a large population study.

C Lahoz1, D Osgood, P W Wilson, E J Schaefer, J M Ordovas.   

Abstract

Apolipoprotein E (apoE) genotypes were determined in a random subset of 1041 subjects enrolled in the Framingham Offspring Study by using DNA amplification followed by restriction isotyping. The results were compared with the apoE phenotypes previously assessed by isoelectric focusing. Discrepancies in apoE allele assignment were found in 98 subjects (9.4%). Both genotype and phenotype were reassessed in these subjects. Genotype misclassification was observed in 20 subjects, whereas the initial phenotype assignment was modified in 46 subjects. No concordance between apoE phenotype and genotype remained in 32 subjects (3.07%). Both methods resulted in similar apoE allele frequencies. Furthermore, no differences were observed regarding the average allelic effect on total cholesterol, LDL cholesterol, or HDL cholesterol concentrations; however, a significant difference was noted on triglyceride concentrations. Our results indicate that most discrepancies between genotype and phenotype assessment of apoE polymorphism were due to sample mishandling, data entry, and technical difficulties rather than true discordances.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8906082

Source DB:  PubMed          Journal:  Clin Chem        ISSN: 0009-9147            Impact factor:   8.327


  12 in total

1.  ABCA1 gene variation and heart disease risk reduction in the elderly during pravastatin treatment.

Authors:  Hironobu Akao; Eliana Polisecki; Ernst J Schaefer; Stella Trompet; Michele Robertson; Ian Ford; J Wouter Jukema; Anton J M de Craen; Christopher Packard; Brendan M Buckley; Kouji Kajinami
Journal:  Atherosclerosis       Date:  2014-05-08       Impact factor: 5.162

2.  Amyloid-associated depression: a prodromal depression of Alzheimer disease?

Authors:  Xiaoyan Sun; David C Steffens; Rhoda Au; Marshal Folstein; Paul Summergrad; Jacqueline Yee; Irwin Rosenberg; D Mkaya Mwamburi; Wei Qiao Qiu
Journal:  Arch Gen Psychiatry       Date:  2008-05

3.  The association between small vessel infarcts and the activities of amyloid-β peptide degrading proteases in apolipoprotein E4 allele carriers.

Authors:  Haihao Zhu; Rafeeque A Bhadelia; Zhiheng Liu; Linh Vu; Huajie Li; Tammy Scott; Peter Bergethon; Mkaya Mwamburi; James L Rosenzweig; Irwine Rosenberg; Wei Qiao Qiu
Journal:  Angiology       Date:  2012-10-17       Impact factor: 3.619

4.  Amyloid-associated depression and ApoE4 allele: longitudinal follow-up for the development of Alzheimer's disease.

Authors:  Wei Qiao Qiu; Haihao Zhu; Michael Dean; Zhiheng Liu; Linh Vu; Guanguang Fan; Huajie Li; Mkaya Mwamburi; David C Steffens; Rhoda Au
Journal:  Int J Geriatr Psychiatry       Date:  2015-08-06       Impact factor: 3.485

5.  Genetic variation at the NPC1L1 gene locus, plasma lipoproteins, and heart disease risk in the elderly.

Authors:  Eliana Polisecki; Inga Peter; Jason S Simon; Robert A Hegele; Michele Robertson; Ian Ford; James Shepherd; Christopher Packard; J Wouter Jukema; Anton J M de Craen; Rudi G J Westendorp; Brendan M Buckley; Ernst J Schaefer
Journal:  J Lipid Res       Date:  2009-09-14       Impact factor: 5.922

6.  Depression and plasma amyloid beta peptides in the elderly with and without the apolipoprotein E4 allele.

Authors:  Xiaoyan Sun; Chi Chia Chiu; Elizabeth Liebson; Natalia A Crivello; Lixia Wang; Joshua Claunch; Marshal Folstein; Irwin Rosenberg; D Mkaya Mwamburi; Inga Peter; Wei Qiao Qiu
Journal:  Alzheimer Dis Assoc Disord       Date:  2009 Jul-Sep       Impact factor: 2.703

7.  Angiotensin converting enzyme inhibitors and Alzheimer disease in the presence of the apolipoprotein E4 allele.

Authors:  Wendy Wei Qiao Qiu; Angela Lai; Timothy Mon; Mkaya Mwamburi; Warren Taylor; James Rosenzweig; Neil Kowall; Robert Stern; Haihao Zhu; David C Steffens
Journal:  Am J Geriatr Psychiatry       Date:  2013-04-03       Impact factor: 4.105

8.  Age and its association with low insulin and high amyloid-β peptides in blood.

Authors:  Huajie Li; Haihao Zhu; Max Wallack; Mkaya Mwamburi; Samer O Abdul-Hay; Malcolm A Leissring; Wei Qiao Qiu
Journal:  J Alzheimers Dis       Date:  2016       Impact factor: 4.472

9.  Genetic variation at the PCSK9 locus moderately lowers low-density lipoprotein cholesterol levels, but does not significantly lower vascular disease risk in an elderly population.

Authors:  Eliana Polisecki; Inga Peter; Michele Robertson; Alex D McMahon; Ian Ford; Christopher Packard; James Shepherd; J Wouter Jukema; Gerard J Blauw; Rudi G J Westendorp; Anton J M de Craen; Stella Trompet; Brendan M Buckley; Michael B Murphy; Jose M Ordovas; Ernst J Schaefer
Journal:  Atherosclerosis       Date:  2008-02-08       Impact factor: 5.162

10.  Genetic variation at the LDL receptor and HMG-CoA reductase gene loci, lipid levels, statin response, and cardiovascular disease incidence in PROSPER.

Authors:  Eliana Polisecki; Hind Muallem; Nobuyo Maeda; Inga Peter; Michele Robertson; Alex D McMahon; Ian Ford; Christopher Packard; James Shepherd; J Wouter Jukema; Rudi G J Westendorp; Anton J M de Craen; Brendan M Buckley; Jose M Ordovas; Ernst J Schaefer
Journal:  Atherosclerosis       Date:  2008-02-07       Impact factor: 5.162

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.